The prognostic value of kidney failure based on glomerular filtration rate in predicting long in-hospital outcomes in patients with unstable angina
Cardiovascular Biomedicine Journal · 2023
DOI: 10.18502/cbj.v2i2.12161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Biomedicine Journal, 2023. Verfasst von Venus Shahabi Raberi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Objectives
Numerous recent studies have emphasized the role of kidney failure in developing ischemic heart disease (IHD) and the resulting adverse consequences. The purpose of the present study was to quantitatively assess the effect of kidney failure based on glomerular filtration rate (GFR) in predicting clinical outcomes in patients with unstable angina (U/A).
Methods
This retrospective cohort study included 129 patients with unstable angina with preserved left ventricular function. Serum creatinine levels were specified at the beginning of their admission. The GFR at admission time was determined based on the MDRD index. Based on the GFR value, patients were classified into two groups, i.e., normal GFR (>60) and decreased GFR (
Zitieren
APA
Raberi, V. S., Parizad, R., & Zadeh, R. F. (2023). The prognostic value of kidney failure based on glomerular filtration rate in predicting long in-hospital outcomes in patients with unstable angina. Cardiovascular Biomedicine Journal. https://doi.org/10.18502/cbj.v2i2.12161
Vancouver
Raberi VS, Parizad R, Zadeh RF. The prognostic value of kidney failure based on glomerular filtration rate in predicting long in-hospital outcomes in patients with unstable angina. Cardiovascular Biomedicine Journal. 2023. doi:10.18502/cbj.v2i2.12161
BibTeX
@article{Raberi2023,
author = {Raberi, Venus Shahabi and Parizad, Razieh and Zadeh, Reza Faramarz},
title = {The prognostic value of kidney failure based on glomerular filtration rate in predicting long in-hospital outcomes in patients with unstable angina},
journal = {Cardiovascular Biomedicine Journal},
year = {2023},
doi = {10.18502/cbj.v2i2.12161}
}
EUVIMED